本文へ移動
cccskills
無料GitHub で公開

esa-pa-interpret-oral-sodium-loading

This skill interprets the oral sodium loading test for primary aldosteronism by evaluating 24‑hour urinary aldosterone excretion after a high‑sodium diet. Use when reviewing results of an "oral sodium loading test" for PA diagnosis; trigger phrases include "urinary aldosterone excretion ≤10 g/24 h" (PA unlikely) or "≥12 g/24 h (Mayo) / ≥14 g/24 h (Cleveland)" (PA highly likely).

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md2.8 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Interpret Oral Sodium Loading Test for PA

STEP 1 — Gather Information

Collect 24‑hour urinary aldosterone excretion (g/24h) after 3 days of oral sodium loading (~200 mmol Na⁺/day). Verify adequate slow‑release potassium supplementation, absence of severe uncontrolled hypertension, renal insufficiency, cardiac arrhythmia, or severe hypokalemia, and confirm proper urine collection timing (morning of day 3 to morning of day 4).

STEP 2 — Rule In / Rule Out

Is urinary aldosterone excretion ≤10 g/24h?

  • Yes → PA is unlikely (proceed to Step 4 – Decide: rule out PA).
  • No → proceed to Step 3.

STEP 3 — Classify or Stratify

Is excretion ≥12 g/24h (Mayo Clinic) or ≥14 g/24h (Cleveland Clinic)?

  • Yes → PA is highly likely.
  • No (10 g/24h < excretion < cutoff) → indeterminate range; consider alternative confirmatory testing.

STEP 4 — Decide

  • If PA unlikely: explore other causes of hypertension; avoid unnecessary adrenal work‑up.
  • If PA highly likely: advance to subtype classification (adrenal CT, then AVS if indicated).
  • If indeterminate: repeat the oral sodium loading test or perform another confirmatory test (e.g., saline infusion test, fludrocortisone suppression test).

Clinical Guardrails / Mimics / Pitfalls

Do not perform the test in patients with severe uncontrolled hypertension, renal insufficiency, cardiac arrhythmia, or severe hypokalemia. Ensure potassium supplementation to prevent hypokalemia‑induced false‑low aldosterone. Beware of renal metabolites (e.g., aldosterone‑18‑oxo‑glucuronide) that may blunt assay accuracy; use HPLC‑tandem mass spectrometry when available. Avoid testing in pregnancy. Inadequate 24‑h urine collection invalidates results.

Concrete Clinical Example

A 48‑year‑old woman with resistant hypertension and spontaneous hypokalemia undergoes oral sodium loading; her 24‑h urinary aldosterone excretion is 8 g/24h. Because this is ≤10 g/24h, PA is deemed unlikely, and the clinician investigates other secondary hypertension causes rather than pursuing adrenal venous sampling.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する